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Percutaneous Transhepatic 
Balloon Dilatation of Benign Biliary 
Strictures 
Between February 1981 and June 1984, 15 patients with benign biliary strictures were 
treated with percutaneous transhepatic balloon dilatation. Three of these patients had 
received liver transplants. The treatment began with a course of balloon dilatation 
therapy, after which a stent catheter was left across the stricture. Six weeks later, after 
duct patency had been shown by cholangiography, the stent catheter was removed from 
all but two patients, both of whom had intrahepatic sclerosing cholangitis. After this 
procedure, six patients (40%), including two liver-transplant patients, were stricture-
free after one treatment for periods rangingJrom 27 to 56 months, and were considered 
to be treatment successes. Nine patients (60%) suffered stricture recurrences. In eight 
of these patients, the stricture was heralded by symptoms of either cholangitis or 
jaundice; in one patient, who was on permanent catheter drainage, the stricture was 
discovered only on follow-up cholangiography. All successfully treated patients had only 
one stricture, while all patients with more than one stricture suffered recurrences. Our 
data also suggest a greater responsiveness for anastomotic strictures than for non-
anastomotic strictures. Of the patients with recurrences, five had symptom-free intervals 
of 23 months or more (up to 31 months). The fact that strictures recurred after such long 
periods of time underscores the importance of long-term follow-up. 
In view of the number of patients helped, the favorable experience with post-liver-
transplantation strictures, and the lack of any major complications in our series, percu-
taneous biliary balloon dilatation offers a viable alternative to surgical management of 
benign biliary strictures. 
Until a few years ago, surgery was the only available treatment for biliary 
strictures. Recently. percutaneous biliary balloon dilatation (BBD) has been used 
at several centers for the nonsurgical treatment of benign biliary strictures [1-6]. 
Important features of our series are (1) the long patient follow-up. (2) the relatively 
large number of patients treated at a single center. and (3) the inclusion of patients 
who had received liver transplants. We present our experience with 15 patients 
treated by BBD. 
Materials and Methods 
Fifteen patients met the study criteria by having one or more benign strictures and a 
minimum observation period of 12 months since completion of the initial BBD treatment cycle. 
Thirteen patients were women and two were men. The patients ranged in age from 31 to 81 
years. 
All the patients in the study had had previous hepatobiliary surgery. The operations 
performed included cholecystectomy (with or without primary ductal or biliary-enteric anas-
tomosis). liver transplantation, and hepatic trisegmentectomy. Three patients had sclerosing 
cholangitis and had undergone cholecystectomies. Because of the history of surgical manip~ 
ulation, their extrahepatic duct strictures were considered to be iatrogenic. rather than caused 
by sclerosing cholangitis. 
The strictures were deSignated as (1) duct anastomotic, (2) biliary-enteric anastomotic, and 
(3) duct nonanastomotic. The "duct nonanastomotic" deSignation was given to any stricture 
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that occurred at a nonanastomotic site, even if the patient had an 
anastomosis. 
All the patients in the series had single, extrahepatic duct strictures, 
'except for three patients who had more than one treated stricture. In 
two of these patients, the treated strictures were intrahepatic. The 
other patient had two extrahepatic duct strictures. 
The usual clinical presentation of bile duct obstruction is cholangi-
tis, which was the case in 12 of the 15 patients. The three patients 
without symptoms of cholangitis were the patients who had received 
liver transplants. They presented with abnormal liver function tests. 
The differentiation between transplant rejection and bile duct obstruc-
tion is clinically difficult, especially given that these patients are on 
immunosuppressive medication. Imaging studies in these three pa-
tients showed intrahepatic duct dilatation, which presumably is evi-
dence of an anatomically significant distal duct stricture. It should be 
noted that 12 of 15 patients had intrahepatic duct dilatation. The only 
ones who did not were the patients with sclerosing cholangitis. 
There were seven patients with anastomotic strictures: three with 
strictures at a primary ductal anastomosis and four with strictures at 
a biliary-enteric anastomosis. Eight patients had nonanastomotic duct 
strictures. 
One post-transplantation patient had a nonanastomotic stricture, 
whereas the other two post-transplantation patients had anastomotic 
. strictures. 
The technique of BBD is as follows. A percutaneous transhepatic 
cholangiogram is performed, and a drainage catheter is inserted to 
bridge the stricture. Usual/y, a minimum delay of 2 days is aI/owed 
between insertion of the drainage catheter and the first BBD session. 
Before BBD, as with biliary drainage catheter placement, the patient 
is treated with broad-spectrum antibiotics. 
A balloon is positioned across the stricture over a guidewire. It is 
then inflated three times for 15 to 20 min per inflation at the maximum 
allowable pressure for the balloon. Most of the patients in our series 
were treated with older-type bal/oons that could only be inflated to 
an approximate maximum of 5 atm (5.05 x 105 Pal. More recently, 
high-pressure balloons have been used. 
The bal/oon diameter is chosen on the basis of the estimated 
diameter of the adjacent nonstrictured bile duct. Starting with balloons 
that are slightly smaller than the estimated diameter of the normal 
duct, progressively larger diameters are used on successive days of 
dilatation. Typically, a 6-mm balloon is used initially; then 8-mm, 10-
mm, and possibly 12-mm balloons are used. Rarely have larger 
balloons been used. Usually, the same-diameter bal/oon is used for 
all inflations performed during one day. After the dilatation is con-
cluded, a biliary drainage catheter is reinserted across the strictured 
segment. 
A BBD "session" deSignates a single day on which three balloon 
inflations are performed. Usually, a 1-day rest period is allowed 
between individual sessions. A BBD "cycle" consists of a group of 
two or three BBD sessions clustered within a 5-8 day period. After 
the last session in a BBD cycle, an 8.3- or 1 a-French drainage catheter 
is left in place across the stricture for 6 weeks. The catheter is capped 
for internal drainage before the patient is discharged. The drainage 
catheter is removed after confirming anatomic lumen patency on a 
cholangiogram. In two of the three patients with sclerosing cholangi-
tis, the drainage catheters were never removed because of concern 
that reentry into the patients' nondilated, diseased ducts might not 
be possible in the event of a restricture. In some patients, biliary 
pressure measurements were obtained, though not routinely. 
Follow-up information after BBD has been obtained from subse-
quent hospital ViSits, direct telephone contact With the patients, and/ 
or contact With the referring physicians. Total follow-up is measured 
from the time the drainage catheter was removed after the initial BBD 
cycle. In those patients whose catheters were never removed, total 
follow-up is measured from the time of the last session of the initial 
BBD cycle. 
Results 
Six (40%) of 15 patients were treated successfully. Treat-
ment was considered successful if patients remained stric-
ture-free after one BBD cycle. Included in this group was a 
patient who had underlying sclerosing cholangitis and a com-
mon bile duct stricture. The stricture was presumed to be 
related to surgical injury during cholecystectomy and common 
duct exploration. She received a liver transplant 36 months 
after BBD, necessitated by hepatic failure due to progressive 
intrahepatic sclerosing cholangitis. Her drainage catheter was 
never removed after BBD. Nonetheless, she is considered a 
BBD success because, at surgery, the previously treated 
common bile duct was still patent. All other patients in this 
group have been stricture-free for periods ranging from 27 to 
56 months without further treatment; four of these have been 
stricture-free for 42 months or more. Four (67%) of six 
successfully treated patients had anastomotic strictures. 
The nine remaining patients who experienced temporary 
relief followed by restricture enjoyed symptom-free intervals 
of varying length. The symptom-free interval is defined as the 
time period between the removal of the drainage catheter 
after a BBD cycle and the discovery of a restricture. This time 
period serves as a measure of symptom remiSSion after BBD. 
In anyone patient with multiple recurrences, there have been 
large differences between the longest and shortest symptom-
free intervals. In all but one patient, stricture recurrence was 
heralded by symptoms of cholangitis or jaundice; one patient 
had sclerosing cholangitiS and had never had her drainage 
catheter removed. Her restricture was discovered on routine 
follow-up cholangiography. Six (67%) of the nine patients with 
restrictures had non anastomotic strictures. 
Five patients with temporary relief followed by restricture 
enjoyed symptom-free intervals of 23 months or more. One 
of these patients had been symptom-free for 31 months after 
the initial BBD cycle before restricture occurred. One of the 
post-transplantation patients has been stricture-free for 31 
months, but only after a second BBD cycle that was neces-
sitated by a restricture 4 months after the first BBD cycle, 
There were two patients in the restricture group whose 
course differed from that of the other patients. One patient 
died from progressive liver failure. She had initially presented 
for liver transplantation, but was deemed ineligible because 
she was 67 years old. The other patient had four restrictures 
after the initial BBD cycle, and the symptom-free intervals 
were so short that she finally underwent surgical revision of 
her duct. 
The complications of BBD were minor. These consisted of 
pain during balloon inflation and hemobilia after BBD. The use 
of lidocaine, directly instilled into the biliary tree immediately 
before balloon inflation, in conjunction with IV hydromorphone 
(1-2 mg), appears to almost eliminate the pain of dilatation. 
The hemobilia, in our experience, has been self-limited, and 
has never necessitated transfusion. 
It should be noted that often the dilated stricture did not 
appear to have improved on the immediate post-BBD cholan-
giogram, but significant improvement was seen on the pre-
BBD cholangiogram of the subsequent session. Tt,ic; phenom-
enon is probably attributable to acute ~;de:na of the duct 
immediately after dilatation. 
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Discussion 
Benign bile duct strictures are generally a postoperative 
complication. In a series of 2665 noncancerous biliary stric-
tures, 1539 (58%) of these were due to surgical trauma [7]. 
Most OJ the operations have been cholecystectomies, which 
was the case in 10 of our 15 patients. The advent of liver 
transplantation and extensive hepatic trisegmentectomies has 
created other sources of iatrogenic strictures. This was the 
case in five out of 15 patients, three of whom had received 
liver transplants, and two of whom had undergone hepatiC 
trisegmentectomies. Surgery has been the traditional method 
of managing biliary strictures, and some authors have re-
ported reasonably good repair rates [8-11]. However, restric-
ture is a major problem. Recurrence rates have been reported 
as high as 45% for end-to-end anastomoses and as high as 
32% for biliary-enteric anastomoses [11]. Surgical bile duct 
repair has an associated mortality, reported to be as high as 
13%, and often results in loss of ductal tissue available for 
any subsequent revision. Also, surgical revision of proximal 
strictures near the porta hepatis is difficult and is nearly 
impossible in the case of intrahepatic duct strictures [11]. 
Thus, a nonsurgical technique that does not require general 
anesthesia is a significant addition to the available treatment 
options. 
Our results should be viewed in the context of the type of 
patients referred. Many of our patients had clinical and labo-
ratory evidence of advanced liver disease. Five patients were 
actually referred for liver transplantation. Percutaneous BBD 
was performed as a last resort before proceeding to trans-
plantation. In such patients, providing a relatively symptom-
free interval, even if only for 6 months, should be considered 
worthwhile. The one death in the series was that of a woman 
who was initially referred for transplantation but who was 
disqualified on the basis of her age (67 years). Because of a 
long history of recurrent cholangitis, she had severely dam-
aged liver function and died of progressive liver failure. 
Of the five patients referred for liver transplantation, two 
were successfully managed with only BBD. One of these two 
patients had undergone a cholecystectomy 8 years earlier, 
followed by five subsequent failed surgical revisions of her 
hepaticojejunostomy. This patient has enjoyed the best result 
so far. She has been symptom-free for 56 months after one 
BBD cycle. The other patient referred for transplantation, but 
treated successfully with only BBD, had sclerosing cholangitis 
and progressive liver failure and responded to one BBD cycle. 
She has been symptom-free for 52 months. The one patient 
in the series who actually proceeded to liver transplantation 
is considered a BBD success because her previously stric-
tured extrahepatic duct was widely patent at the time of 
transplantation 36 months after BBD treatment. 
Of the three patients with post-liver-transplantation stric-
tures, two were treated successfully. Their strictures were at 
the choledochocholedochostomy anastomosis. The third 
post-transplantation patient had a nonanastomotic stricture. 
She restrictured 4 months after the initial BBD cycle. After a 
second cycle, she remains asymptomatic 31 months later. 
Thus, in this patient, BBD has precluded the need for surgical 
reviSion. Because of the single restricture, she is included in 
the temporary--8Iief·,r,:th:estricture category, rather than 
being considered a treatment success. 
That restricturing occurs is disappointing. However, of the 
nine patients who restrictured after BBD, five (56%) had 
maximum symptom-tree intervals of at least 23 months. Thus, 
despite restricture, most patients in this group were helped 
for long periods of time by BBD. The importance of long-term 
follow-up is illustrated by the recurrence of a stricture after 
31 months. 
Although the numbers are small, our data suggest that 
patients with more than one stricture are more likely to have 
a recurrence. The three patients in our series (20%) with two 
or more strictures have all suffered more than one stricture 
recurrence. Also, our data suggest that anastomotic strictures 
are more responsive to BBD than are non anastomotic stric-
tures. 
We postulate that anastomotic strictures are localized nar-
rowings caused by circumferential fibrosis, probably induced 
by wound-healing. Nonanastomotic strictures possibly arise 
as a result of ductal ischemia from a variety of causes, 
including inadvertent stretching or crushing during surgery 
[11] and hepatiC artery occlusion [12]. The reason for the 
apparent reduced responsiveness of nonanastomotic stric-
tures to BBD is uncertain, but it may be related to eccentricity 
of the stricture and/or thicker, more tenacious periductal 
fibrosis in the area of the stricture. 
There are unanswered questions concerning BBD tech-
nique. The optimal length of time that the balloon should be 
left inflated across the stricture is unknown. We have arbi-
trarily selected 15-20 min per inflation, repeating this three 
times, with several minutes of deflation in between. Salamo-
nowitz et al. [4] have tried inflations lasting 24 hr. This raises 
the theoretical question of whether there is an increased risk 
of bile duct ischemia if the balloon is kept inflated beyond a 
certain time. Another unanswered question concerns the 
length of time a stent catheter needs to be kept across the 
dilated stricture. Warren et al. [11] suggest that a postoper-
ative anastomosis should be stented for at least 6 months 
and preferably 1 year or more. Others have questioned 
whether long-term stenting may do more harm than good, 
even accelerating the process of restricture [6, 13, 14]. We 
have arbitrarily chosen to stent our patients for 6 weeks after 
the last BBD session of the cycle. Finally, how long need a 
patient be stricture-free before being considered "cured"? 
Despite the fact that one patient restrictured after 31 months, 
four patients who are currently stricture-free have been so 
for 42 months or more, and their outlook for continued 
stricture-free existence is probably good. One of these four 
patients, however, still has underlying sclerosing cholangitis. 
Longer follow-up in more patients is required to answer these 
questions. 
In conclusion, patients who have severe progressive he-
patic failure or a history of multiple failed surgical anastomotic 
revisions can benefit from BBD, forestalling and sometimes 
obviating further surgical procedures or liver transplantation. 
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